CLINICAL_TRIALS
trial_result
· 2024-05-24
Clinical Trial Update: Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) [Phase 2]
Summary
A Phase 2 trial evaluating guselkumab for pityriasis rubra pilaris has completed and results were posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oregon Health and Science University | Conditions: Pityriasis Rubra Pilaris | Phase 2 | Status: COMPLETED | Results posted: 2024-05-24